Patents Assigned to Medicis Pharmaceutical Corporation
  • Patent number: 7189759
    Abstract: The present invention addresses the problem of excessive discoloration in hydroquinone compositions of a neutral pH. Antioxidants in the hydroquinone phase and inorganic or amino acyl cationic salts of acidic ascorbyl esters, preferably sodium metabisulfite and magnesium ascorbyl phosphate respectively, are effective in stabilizing such hydroquinone compositions, which are used in treatment of pigmentation disorders. Protected retinoid may be added to these compositions for additional skin benefit effects.
    Type: Grant
    Filed: May 23, 2001
    Date of Patent: March 13, 2007
    Assignee: Medicis Pharmaceutical Corporation
    Inventors: Mitchell S. Wortzman, Philip J. Gordon, Eugene H. Gans, Bhiku G. Patel
  • Patent number: 7025977
    Abstract: The present invention addresses the problem of excessive discoloration in hydroquinone compositions of a neutral pH. Antioxidants in the hydroquinone phase and inorganic or amino acyl cationic salts of acidic ascorbyl esters, preferably sodium metabisulfite and magnesium ascorbyl phosphate respectively, are effective in stabilizing such hydroquinone compositions, which are used in treatment of pigmentation disorders. Protected retinoid may be added to these compositions for additional skin benefit effects.
    Type: Grant
    Filed: July 10, 2003
    Date of Patent: April 11, 2006
    Assignee: Medicis Pharmaceutical Corporation
    Inventors: Mitchell Wortzman, Philip J. Gordon, Eugene H. Gans, Bhiku G. Patel
  • Patent number: 6998130
    Abstract: The present invention addresses the problem of excessive discoloration in hydroquinone compositions of a neutral pH. Antioxidants in the hydroquinone phase and inorganic or amino acyl cationic salts of acidic ascorbyl esters, preferably sodium metabisulfite and magnesium ascorbyl phosphate respectively, are effective in stabilizing such hydroquinone compositions, which are used in treatment of pigmentation disorders. Protected retinoid may be added to these compositions for additional skin benefit effects.
    Type: Grant
    Filed: July 10, 2003
    Date of Patent: February 14, 2006
    Assignee: Medicis Pharmaceutical Corporation
    Inventors: Mitchell S. Wortzman, Philip J. Gordon, Eugene H. Gans, Bhiku G. Patel
  • Patent number: 6964776
    Abstract: The present invention addresses the problem of excessive discoloration in hydroquinone compositions of a neutral pH. Antioxidants in the hydroquinone phase and inorganic or amino acyl cationic salts of acidic ascorbyl esters, preferably sodium metabisulfite and magnesium ascorbyl phosphate respectively, are effective in stabilizing such hydroquinone compositions, which are used in treatment of pigmentation disorders. Protected retinoid may be added to these compositions for additional skin benefit effects.
    Type: Grant
    Filed: April 14, 2003
    Date of Patent: November 15, 2005
    Assignee: Medicis Pharmaceuticals Corporation
    Inventors: Mitchell S. Wortzman, Philip J. Gordon, Eugene H. Gans, Bhiku G. Patel
  • Patent number: 6955825
    Abstract: A composition and method for delivering sulfur to skin and absorbing irritants in the skin. A high sorption base is employed which comprises non-swelling clay, gum, swelling clay, silicon and combinations thereof. The absorption of the irritants does not hinder the delivery of the active ingredient to the skin.
    Type: Grant
    Filed: April 21, 2004
    Date of Patent: October 18, 2005
    Assignee: Medicis Pharmaceutical Corporation
    Inventors: Jonah Shacknai, Eugene H. Gans
  • Patent number: 6905675
    Abstract: A method for reducing the production of malodor in sulfur containing dermatological compositions by adjusting the pH of the composition to between about 6.5 to about 8.1. Also, sulfur containing dermatological compositions having a pH between about 6.5 and about 8.1.
    Type: Grant
    Filed: October 29, 2002
    Date of Patent: June 14, 2005
    Assignee: Medicis Pharmaceutical Corporation
    Inventors: Jonah Shacknai, Eugene H. Gans, Ray Figureoa
  • Patent number: 6855342
    Abstract: A composition and method for delivering sulfur to skin and absorbing irritants in the skin. A high sorption base is employed which comprises non-swelling clay, gum, swelling clay, silicon and combinations thereof. The absorption of the irritants does not hinder the delivery of the active ingredient to the skin.
    Type: Grant
    Filed: December 18, 2001
    Date of Patent: February 15, 2005
    Assignee: Medicis Pharmaceutical Corporation
    Inventors: Jonah Shacknai, Eugene H. Gans
  • Patent number: 6787160
    Abstract: A composition and method for delivering sulfur to skin and absorbing irritants in the skin. A high sorption base is employed which comprises non-swelling clay, gum, swelling clay, silicon and combinations thereof. The absorption of the irritants does not hinder the delivery of the active ingredient to the skin.
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: September 7, 2004
    Assignee: Medicis Pharmaceutical Corporation
    Inventors: Jonah Shacknai, Eugene H. Gans
  • Patent number: 6765001
    Abstract: The present invention comprises a composition, method of enhancing potency and method of delivering corticosteroids in a vehicle comprising at least two penetration enhancers, and solvents and emulsifiers. The propylene glycol and penetration enhancers are present in ratio to the total of the propylene glycol, penetration enhancers, and solvents and emulsifiers of at least about 0.70.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: July 20, 2004
    Assignee: Medicis Pharmaceutical Corporation
    Inventors: Eugene H. Gans, Mitchell S. Wortzman
  • Publication number: 20040057972
    Abstract: A method for reducing the production of malodor in sulfur containing dermatological compositions by adjusting the pH of the composition to between about 6.5 to about 8.1. Also, sulfur containing dermatological compositions having a pH between about 6.5 and about 8.1.
    Type: Application
    Filed: October 29, 2002
    Publication date: March 25, 2004
    Applicant: MEDICIS PHARMACEUTICAL CORPORATION
    Inventors: JONAH SHACKNAI, Eugene H. Gans, Ray Figureoa
  • Publication number: 20030130247
    Abstract: The present invention comprises a composition, method of enhancing potency and method of delivering corticosteroids in a vehicle comprising at least two penetration enhancers, and solvents and emulsifiers. The propylene glycol and penetration enhancers are present in ratio to the total of the propylene glycol, penetration enhancers, and solvents and emulsifiers of at least about 0.70.
    Type: Application
    Filed: December 21, 2001
    Publication date: July 10, 2003
    Applicant: Medicis Pharmaceutical Corporation
    Inventors: Eugene H. Gans, Mitchell S. Wortzman
  • Patent number: 6586473
    Abstract: A topical composition for delivering an effective amount of a pharmaceutically acceptable drug, including laureth-4, propylene glycol, dimethylsorbide, and a pharmaceutically acceptable diluent is described as an improved drug delivery composition. Further, a method of transepithelial delivery of a drug to a human by topical application to the skin of a human of a composition including laureth-4, propylene glycol, dimethylsorbide, a pharmaceutically acceptable diluent of water and ethanol and an effective amount of a pharmaceutically acceptable drug has beneficial delivery effects.
    Type: Grant
    Filed: January 12, 2000
    Date of Patent: July 1, 2003
    Assignee: Medicis Pharmaceutical Corporation
    Inventors: Thomas P. Nigra, Eugene H. Gans
  • Publication number: 20020164381
    Abstract: Methods for the treatment and prevention of cutaneous mites and for the treatment and prevention of cutaneous inflammation of mammalian skin associated with cutaneous mite infestations utilizing compositions comprising sulfur, one or more sulfur derivative and a dermatologically acceptable carrier. The composition is preferably a cleanser.
    Type: Application
    Filed: December 18, 2001
    Publication date: November 7, 2002
    Applicant: Medicis Pharmaceutical Corporation
    Inventors: Jonah Shacknai, Eugene H. Gans
  • Publication number: 20020132015
    Abstract: A composition and method for delivering sulfur to skin and absorbing irritants in the skin. A high sorption base is employed which comprises non-swelling clay, gum, swelling clay, silicon and combinations thereof. The absorption of the irritants does not hinder the delivery of the active ingredient to the skin.
    Type: Application
    Filed: December 18, 2001
    Publication date: September 19, 2002
    Applicant: Medicis Pharmaceutical Corporation
    Inventors: Jonah Shacknai, Eugene H. Gans
  • Patent number: 5336692
    Abstract: High molecular weight petroleum fractions which have a low white oil content are admixed with a volatile siloxane, hexamethyldisiloxane, octamethylcyclotetrasiloxane and/or decamethylcyclopentasiloxane and a compound that is both hydrophobic and hydrophilic to provide an ointment base which enables these petrolatum fractions to be spread easily on the skin. Evaporation of the solvent leaves a high molecular weight petrolatum film on the skin that is nonirritating and yet highly resistant to mechanical removal.
    Type: Grant
    Filed: June 18, 1991
    Date of Patent: August 9, 1994
    Assignee: Medicis Pharmaceutical Corporation
    Inventors: Eugene H. Gans, Hans R. Suess